Because of our busy lifestyle, most of us are unintentionally deficient in the essential vitamins and minerals that our bodies need to perform at their best
The history of GLP-1 agonists is relatively recent, dating back to the late 20th century
But the Danish drugmaker noted that it spent almost $5 billion on research and development last year, and will spend more than $6 billion on a recent deal to boost manufacturing to meet demand for GLP-1s
Researchers found that although these medications, including GLP-1-based treatments like semaglutide and tirzepatide, help patients lose substantial weight while in use, gains tend to return within weeks of stopping
doi: 10.1016/0028-3908(79)90088-1
For those who have been hesitant to cover the medications because of cost, capping employee out-of-pocket costs at $200 would amount to less than half the price consumers pay in cash without insurance if they bought the drug through Ely Lilly or Novo Nordisk's direct-to-consumer websites